| 今开：0.0 | 昨收：0.0105 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：287879.0 |
坚信价值2012-08-04 14:45
Jean-Marie Eveillard 控股：
$居里(CRIS)$ 21%
$因特瓦克(IVAC)$ 15%
$阿连特技术系统(ATK)$ 14%
$代尔提克木材(DEL)$ 13%
$辛塔斯(CTAS)$ 13%
$布朗特国际(BLT)$ 13%
$Myriad Pharmaceuticals(MYRX)$ 10%
$San Juan Basin Royalty Trust(SJT)$ 10%查看全文
$Myriad Pharmaceuticals(MYRX)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2013-07-26 AccNo: 0000921895-13-001482 Size: 567 KB 网页链接
$Myriad Pharmaceuticals(MYRX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2013-07-17 AccNo: 0001144204-13-039919 Size: 7 MB 网页链接
$Myriad Pharmaceuticals(MYRX)$ 美东时间 2013-09-09 Q4 2013 Myrexis, Inc. Earnings Release 网页链接
8-K - Current report Filed: 2012-02-16 AccNo: 0001193125-12-065331 Size: 33 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits 网页链接
8-K - Current report Filed: 2012-02-16 AccNo: 0001193125-12-065331 Size: 33 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000905718-12-000054 Size: 50 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000905718-12-000054 Size: 50 KB 网页链接
8-K - Current report Filed: 2012-02-10 AccNo: 0001193125-12-050985 Size: 83 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits 网页链接
10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2012-02-09 AccNo: 0001193125-12-049292 Size: 1 MB 网页链接
10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2012-02-09 AccNo: 0001193125-12-049292 Size: 1 MB 网页链接